Dr. Joost R. van der Vorst

Joost van der Vorst is a consultant vascular and endovascular surgeon with a great interest in medical imaging with a research focus on imaging of tissue perfusion. Clinically, he is an expert in open and endovascular aortic surgery and the treatment of peripheral arterial disease.

Most recent publications

Willems SA, van der Vorst JR and Brouwers JJWM
Towards uniform case-identification criteria in observational studies on peripheral arterial disease: A scoping review
Keekstra N, Biemond M, van Schaik J, Schepers A, Hamming JF, van der Vorst JR and Lindeman JHN
The diagnosis peripheral arterial disease (PAD) is commonly applied for symptoms related to atherosclerotic obstructions in the lower extremity, though its clinical manifestations range from an abnormal Ankle Brachial Index to critical limb ischemia. Subsequently, management and prognosis of PAD vary widely with the disease stage. A critical aspect is how this variation is addressed in administrative databases-based studies that rely on diagnosis codes for case identification. The objective of this scoping review is to inventory the identification strategies used in studies on PAD that rely on administrative databases, to map the pros and cons of the ICD codes applied, and propose a first outline for a consensus framework for case identification in administrative databases.
Diagnostic accuracy of the maximal systolic acceleration to detect peripheral arterial disease
Willems SA, Dolfing SG, van Wissen RC, van der Vorst JR, van Schaik J, Schepers A, Hamming JF and Brouwers JJWM
Diagnosing peripheral arterial disease (PAD) can be challenging owing to medial arterial calcification (MAC) in patients with diabetes mellitus (DM) and chronic kidney disease (CKD). Current bedside tests, such as the ankle-brachial index and toe-brachial index, are often insufficient. The maximal systolic acceleration (ACC) is a velocimetric Doppler-derived parameter and could be a new promising test in the diagnostic workup of these patients. The primary aim of this study was to evaluate the diagnostic performance of the ACC to detect PAD.
Therapeutic management of in-stent thrombosis after thoracic endovascular aortic repair for blunt thoracic aortic injury in a coronavirus disease 2019 patient
van Rijn K, Schepers A, van der Meer RW, van Rijswijk CSP, van Schaik J and van der Vorst JR
A 27-year-old man underwent thoracic endovascular aortic repair for blunt thoracic aortic injury. Fourteen months later, he presented with intermittent paraplegia, congestive heart failure, and a decline of kidney function as a result of high-grade aortic stenosis caused by in-stent thrombosis. He had a concurrent infection with coronavirus disease 2019. The patient was successfully treated using axillofemoral bypass, followed by stent relining 2 weeks later. The possible risk factors and the optimal therapeutic approach for in-stent thrombosis remain unknown, because only a limited number of cases describing this rare complication have been reported.
The association between sarcopenia and adverse outcomes after complex endovascular aortic repair
Warmerdam BW, van Rijswijk CS, Droop A, Lucassen CJ, Hamming JF, van Schaik J and van der Vorst JR
Sarcopenia is identified as a predictive factor for adverse outcomes after complex endovascular aortic repair (complex EVAR). Consensus on preferred parameters for sarcopenia is not yet reached. The current study compares three CT-assessed parameters on their association with adverse outcomes after complex EVAR.